Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma

Published:2019-10-31 Issue:4 Volume:75 Page:959-962
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

An Jin¹,Lee Ji‐Hyang¹,Won Ha‐Kyeong¹²^ORCID,Kang Yewon¹³,Song Woo‐Jung¹^ORCID,Kwon Hyouk‐Soo¹,Cho You Sook¹,Moon Hee‐Bom¹,Kim Tae‐Bum¹^ORCID

Affiliation:

1. Department of Allergy and Clinical Immunology Asan Medical Center University of Ulsan College of Medicine Seoul Korea

2. Department of Internal Medicine Veterans Health Service Medical Center Seoul Korea

3. Department of Internal Medicine Pusan National University School of Medicine Pusan Korea

Funder

National Science Foundation, United Arab Emirates

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14084

Reference8 articles.

1. The Allergic Asthma Phenotype

2. Allergicvsnonallergic asthma: what makes the difference?

3. Current and future biomarkers in allergic asthma

4. Cellular and immunological markers of allergic and intrinsic bronchial asthma

5. Roles of Mas-related G protein–coupled receptor X2 on mast cell–mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists;Journal of Allergy and Clinical Immunology;2024-07

2. Bergapten inhibits airway inflammation and MRGPRX2-mediated mast cells activation by targeting NR4A1;International Immunopharmacology;2024-03

3. Neuroimmune communication in allergic rhinitis;Frontiers in Neurology;2023-12-21

4. miR-212/132 attenuates OVA-induced airway inflammation by inhibiting mast cells activation through MRGPRX2 and ASAP1;Experimental Cell Research;2023-12

5. Neuroimmune Interactions in the Lung;Annual Review of Immunology;2023-11-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3